Department of Microbiology, Anatomy, Physiology and Pharmacology, La Trobe University, VIC, Australia.
Department of Microbiology, Anatomy, Physiology and Pharmacology, La Trobe University, VIC, Australia.
Trends Mol Med. 2024 May;30(5):443-458. doi: 10.1016/j.molmed.2024.02.003. Epub 2024 Mar 4.
Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a debilitating chronic illness often triggered by an initiating acute event, mainly viral infections. The transition from acute to chronic disease remains unknown, but interest in this phenomenon has escalated since the COVID-19 pandemic and the post-COVID-19 illness, termed 'long COVID' (LC). Both ME/CFS and LC share many clinical similarities. Here, we present recent findings in ME/CFS research focussing on proposed disease pathologies shared with LC. Understanding these disease pathologies and how they influence each other is key to developing effective therapeutics and diagnostic tests. Given that ME/CFS typically has a longer disease duration compared with LC, with symptoms and pathologies evolving over time, ME/CFS may provide insights into the future progression of LC.
肌痛性脑脊髓炎/慢性疲劳综合征(ME/CFS)是一种使人虚弱的慢性疾病,通常由引发的急性事件引起,主要是病毒感染。从急性到慢性疾病的转变尚不清楚,但自 COVID-19 大流行和称为“长新冠”(LC)的新冠后疾病以来,人们对这一现象的兴趣日益增加。ME/CFS 和 LC 有许多临床相似之处。在这里,我们介绍了 ME/CFS 研究中的最新发现,重点是与 LC 共享的拟议疾病病理学。了解这些疾病病理学以及它们如何相互影响是开发有效治疗方法和诊断测试的关键。鉴于 ME/CFS 与 LC 相比通常具有更长的疾病持续时间,症状和病理学随时间演变,ME/CFS 可能为 LC 的未来进展提供见解。